InvestorsHub Logo
Followers 188
Posts 28909
Boards Moderated 1
Alias Born 08/29/2012

Re: namtae post# 388115

Thursday, 09/21/2023 6:32:47 PM

Thursday, September 21, 2023 6:32:47 PM

Post# of 402168
X 1. In house marketing and distribution: Kirkov
—2. Generic OxyContin- FIRST TO FILE
—3. Generic Concerta- $1.2 BILLION
—4. Generic Vyvanse- $5.1 BILLION
—5. Vigabatrin
—6. Patented Unique ADF (w/o naltrexone)-- NDA
—7. Mikah monster
—8. Undisclosed
—9. Antimetabolite ANDA- Methotrexate -$600 Million
—10. Undisclosed Antimetabolite ANDA- $42 Million
—11. Full ownership of Adderall XR
—12. Prasco/Burel Adderall agreement
—13. Dexcel partnership approval by Israeli health for European distribution
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News